TLR9 and STING agonists adjuvanted varicella-zoster virus glycoprotein E induced a potent and durable nasal vaccine response

Herpes zoster is caused by the reactivation of latent varicella-zoster virus (VZV), primarily affecting middle-aged and older individuals and often accompanied by severe pain and other complications. Vaccination is an effective preventive measure against this disease. In the present study, we evalua...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jing-Xing Yang, Po-Yen Lin, Jen-Chih Tseng, Zaida Nur Imana, Yi-Ling Liu, Chih-Feng Tien, Yu-Siang Su, Wan-Ting Tsai, Yu-Wen Su, Jen-Kun Chen, Ming-Hsi Huang, Linyi Chen, Tsung-Hsien Chuang, Guann-Yi Yu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2026-12-01
Saila:	Human Vaccines & Immunotherapeutics
Gaiak:	Adjuvant CpG-containing oligodeoxynucleotides cyclic dinucleotide herpes zoster vaccine
Sarrera elektronikoa:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2615532
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!